Hong Kong-listed AI drug discovery company Insilico Medicine and Eli Lilly sign a drug co-development deal worth up to $2.75B, with $115M in upfront payments (Evelyn Cheng/CNBC)
TechMeme
•
Generative AI
Evelyn Cheng / CNBC: Hong Kong-listed AI drug discovery company Insilico Medicine and Eli Lilly sign a drug co-development deal worth up to $2.75B, with $115M in upfront payments - BEIJING - U. S. pharmaceutical giant Eli Lilly has reached a $2.75B deal to bring drugs developed using artificial intelligence …